Why mash
screening matters

Early screening and timely treatment are essential in stopping, or even reversing, liver damage from MASH (metabolic dysfunction–associated steatohepatitis).

Image of a woman grooming a dog

Most people with MASH are undiagnosed

MASH symptoms can sometimes be hard to detect

MASH symptoms can be vague, nonspecific, or even absent. Some people who reported MASH symptoms prior to getting diagnosed experienced:

Abdominal pain icon

Abdominal pain

Nausea icon

Nausea

Loss of appetite icon

Loss of appetite

Fatigue icon

Fatigue

Swelling in the abdomen icon

Swelling in the abdomen

Because symptoms may not clearly indicate this disease, it's important to be aware of certain risk factors that may increase the likelihood of developing MASH.

See risk factors

How common is MASH?

About 1 out of 3 adults in the US living with fatty liver disease icon

~1 out of 3 adults in the United States is living with fatty liver disease 

1 in 20 adults in the US living with MASH icon

1 in 20 adults in the United States is living with MASH 


PREVALENCE OF MASH AMONG RACIAL AND ETHNIC GROUPS IN THE UNITED STATES*

Prevalence by race of people with MASH in the US infographic: 45% Hispanic, 32% White, 20% African American

*Percentages represent combined data from multiple medical studies of people living with fatty liver disease and do not add up to 100%.

Half of the people in the US with MASH are Hispanic icon

Certain people may also be at higher risk for fatty liver disease, which can progress to MASH, like  those of Hispanic or Asian descent with specific genetic risk factors.

Screening can expose MASH

Getting screened for MASH gives you the best opportunity for early detection, so you can take action. Why does this matter? When MASH is addressed early, liver damage may be stopped or even reversed.

Some health care professionals refer to MASH as a "silent" disease because many people do not experience symptoms. Even if they do, they may not connect those symptoms to MASH. 

Advanced stages of MASH come with potential complications that may be anything but quiet, like liver cancer or liver failure due to cirrhosis. Fortunately, timely screening, detection, and management may help prevent future complications.

Icon of physician with a speech bubble containing a question mark

For more help navigating the conversation with your doctor, download these discussion guides.

Talk to Your Doctor guide
Doctor Visit Checklist
Image of a woman sitting at a table across from a client

Getting screened for MASH
may be easier than you think

Wondering about your risk for fatty liver disease or if existing fatty liver disease has progressed to MASH?
With the development of noninvasive testing options, it may be easier than you think to test for fatty liver disease and MASH. 

Learn more about MASH testing
Liver icon with a question mark

Learn if you could be at risk for MASH

See what risk factors and other common conditions are associated with MASH.

Take the MASH risk quiz

The information provided is for educational purposes only.

Continue

You are now leaving the Novo Nordisk US affiliate site. Novo Nordisk is not responsible for the content of the site you are about to visit.

Continue